chr16-75641616-T-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005548.3(KARS1):c.170A>C(p.Asn57Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,613,936 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N57I) has been classified as Uncertain significance.
Frequency
Consequence
NM_005548.3 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 89Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P
- leukoencephalopathy, progressive, infantile-onset, with or without deafnessInheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease recessive intermediate BInheritance: AR, Unknown Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nonsyndromic genetic hearing lossInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KARS1 | NM_005548.3 | c.170A>C | p.Asn57Thr | missense_variant | Exon 2 of 14 | ENST00000302445.8 | NP_005539.1 | |
| KARS1 | NM_001130089.2 | c.254A>C | p.Asn85Thr | missense_variant | Exon 3 of 15 | NP_001123561.1 | ||
| KARS1 | NM_001378148.1 | c.-299A>C | 5_prime_UTR_variant | Exon 2 of 14 | NP_001365077.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152118Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251330 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461700Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727160 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152236Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74446 show subpopulations
ClinVar
Submissions by phenotype
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with KARS-related conditions. This variant is present in population databases (rs117041419, gnomAD 0.003%). This sequence change replaces asparagine, which is neutral and polar, with threonine, which is neutral and polar, at codon 85 of the KARS protein (p.Asn85Thr). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at